Reproductive factors, menopausal hormone therapy, and risk of non-Hodgkin, diffuse large B-cell and follicular lymphomas: a UK case–control study

By Mildon Katherine  

Cancer Causes and Control, Vol. 21, Iss. 12, 2010-12 ,pp. : 2079-2083

Springer Publishing Company

Access to resources Recommend Favorite

CD20-specific antibody-targeted chemotherapy of non-Hodgkin’s B-cell lymphoma using calicheamicin-conjugated rituximab

By DiJoseph John   Dougher Maureen   Armellino Douglas   Kalyandrug Lyka   Kunz Arthur   Boghaert Erwin   Hamann Philip   Damle Nitin  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 7, 2007-07 ,pp. : 1107-1117

Springer Publishing Company

Access to resources Recommend Favorite

Non-Hodgkin's Lymphomas--Current Status of Therapy and Future Perspectives

By Hiddemann W.  

European Journal of Cancer, Vol. 31, Iss. 13, 1995-12 ,pp. : 2141-2145

Elsevier

Access to resources Recommend Favorite

PF-04691502, a dual PI3K/mTOR inhibitor has potent pre-clinical activity by inducing apoptosis and G1 cell cycle arrest in aggressive B-cell non-Hodgkin lymphomas

By            

International Journal of Oncology, Vol. 48, Iss. 1, 2016-01 ,pp. : 253-260

Spandidos Publications

Access to resources Recommend Favorite

The Follicular Non-Hodgkin's Lymphomas--I. The Possibility of Cure

By Denham J.W.   Denham E.   Dear K.B.   Hudson G.V.  

European Journal of Cancer, Vol. 32, Iss. 3, 1996-03 ,pp. : 470-479

Elsevier

Access to resources Recommend Favorite